SKI Market

A+| A| A-|

Indian Indices

Sensex

77,763.91 261.79
( 0.34%)

Global Indices

Nasdaq

52,921.07 594.83
(1.14%)

Dow Jones

7,504.24 0.01
(0.00%)

Hang Seng

69,733.68 1,000.53
(1.46%)

Nikkei 225

10,673.34 20.47
(0.19%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dipna Pharmachem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543594

INE0MC401013

23.697614

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

5.92

15.56

EPS(TTM)

Face Value()

Div & Yield %

Back

Strides Pharma Science consolidated net profit rises 129.80% in the December 2025 quarter

Jan 30,2026

Net profit of Strides Pharma Science rose 129.80% to Rs 202.11 crore in the quarter ended December 2025 as against Rs 87.95 crore during the previous quarter ended December 2024. Sales rose 3.55% to Rs 1194.65 crore in the quarter ended December 2025 as against Rs 1153.67 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1194.65	1153.67	4
OPM %	19.75	18.23	-
PBDT	299.40	164.70	82
PBT	248.78	116.28	114
NP	202.11	87.95	130

77,763.91 261.79 ( 0.34%)

52,921.07 594.83 (1.14%)

7,504.24 0.01 (0.00%)

69,733.68 1,000.53 (1.46%)

10,673.34 20.47 (0.19%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)